AVRA Technology Award–2021 presented to Bharat Biotech chairman
Need to create an ecosystem where India innovates and not copies, says awardee Krishna M Ella
Can nasal vaccines shield against breakthrough infections?
New study argues that nasal vaccines may be necessary to achieve more robust immunity and protection from reinfection by future variants
Millions of doses set to expire by September as India’s COVID-19 vaccination drive stagnates
Share of population completely vaccinated grew just 5 percentage points since April
COVID-19: India trips on its patent waiver proposal
New Delhi has not backed its WTO proposal to suspend intellectual property rights on COVID-19 pharma products with robust action
No mixing of vaccines in India for booster dose. What do experts say?
Studies point to better protection with mixed doses; experts call data ‘fragmentary’
Omicron variant: How should India deal with a fresh surge in COVID-19 cases?
India reported 1,700 omicron cases as of January 3
With omicron reinfections, are we back to square one of the pandemic?
Case surge may not be as bad as during India's 2nd wave but lot depends on govt interventions, citizen behaviour, say experts
COVID-19: First few peer reviewed studies suggest vaccine induced antibodies fail to protect from Omicron
The studies, published in Nature, covered Oxford-AstraZeneca vaccine, but not India’s indigenous Covaxin
What are India’s options for a booster dose of COVID-19 vaccine
Hyderabad-based Biological E’s Corbevax and SII’s Covovax, both of which are protein-based vaccines, are India’s best bet for a …
As told to Parliament (December 7, 2021): Thousands of posts vacant at India’s rural health centres
All that was discussed in the House through the day
Omicron threat: How fast is India vaccinating against COVID-19
Rate too slow to meet target of vaccinating every eligible by end of year. The question is: Can Omicron further derail India’s fight …
Moderna’s brazen patent grab on a COVID-19 jab
The US administration is finally putting its foot down on the appropriation of public research by drug firms
WHO finally gives emergency use nod for Covaxin
Those administered indigenous Indian vaccine against COVID-19 can now travel abroad unhindred
Covaxin has not got emergency use approval from WHO since 6 months. Know the process here
The approval is stuck in the final fifth stage of the process when clinical data on safety, efficacy, quality and risk management plan are evaluated
COVID-19: Expert committee approves Covaxin for children aged 2-18 years
No data on clinical trials of Bharat Biotech vaccine on children available publicly yet
Lateral thoughts: COVID-19 vaccines and a game of chance
Would you be compensated for adverse reactions to the COVID-19 vaccines?
COVID-19 vaccination drive hits a pause in Odisha’s 11 districts
After administering 0.3 million doses June 21, the state has run out of vaccines; the drive expected to resume July 2
Free COVID-19 vaccines in India from June 21: Everything you need to know
The Centre will buy 75% of total vaccine production and give it to states free of cost
Delta variant of COVID-19 can infect vaccinated people finds AIIMS study
COVID-19 vaccine: After doses, states struggle to get syringes
Manufacturers foresaw demand boom, asked Centre to draw up plan in 2020 itself
Is WHO nod for China’s Sinovac a domino effect of COVID-19 second wave in India?
The process of approval has become slower since Pfizer and BioNTech received approval
No response to global COVID-19 vaccine tender; Odisha too knocks at Centre’s door
Many manufacturers seemed to be willing to deal with federal-level central procurement, said state health minister
COVID-19 vaccine update: SC quizzes Centre on mandatory online registration, dual pricing
You keep saying digital India, digital India, but you are not aware of the ground realities: Justice Chandrachud
Confronting head-on the vexed pricing of COVID -19 vaccines
It would cost anything between Rs 13,821 crore to Rs 1,10,568 crore to vaccinate the 20-44 age population
Growing COVID-19 infection among children a concern in Odisha: Sources
Of the total cases registered between March 1 and May 16, 8% were among those under 18
